MPC1 and acute myeloid leukemia: Thus, we used the deletion of MPC1 as a tool to reduce OXPHOS in human AML MV4-11 and Molm-14 cells (Schell et al., 2017; Ramstead et al., 2020; De La Rossa et al., 2022).